Get the latest updates in your mailbox by subscribing to our newsletter.
UK B1.1.7 SARS-CoV-2 pseudoviruses
**UK B1.1.7 SARS-CoV-2 pseudoviruses available for Neutralization assay: **Preclinics is offering its Customers the Pseudoviral Infection/Neutralization assay with recent mutated strain B1.1.7.
Photo by CDC from Pexels
preclinics is developing assays for SARS-CoV-2 and COVID-19 research. Now our virus neutralizing assays are available to test the neutralizing effect of antibodies and sera. Assays for protease inhibitors, as well as in vivo models in K18-huACE2 mice will follow soon. For covid19 research we have a lung inflammation model established.
COVID-19 Pseudovirus Infection and Neutralisation Service
Preclinics GmbH offers its customers Covid-19 pseudotyped viruses infection and neutralization services in vitro and ex vivo. This service is based on the crucial interaction of trimeric Spike protein of SARS-Cov2 with its eukaryotic counter receptor ACE2.
This service can be used for:
1. Screening patient serum for neutralizing antibodies
2. Validating inhibitors of the Spike-ACE2 interaction
3. COVID-19 vaccine development
**Assay lay out**
We look forward to welcoming you at the Nanobodies (Hybrid 2nd edition) Symposium on 08-09 September 2021 in Brussels. Let`s talk together about our services, products and common interests.
For more information please click (link: https://www.vibconferences.be/events/nanobodies-hybrid-2nd-edition text: **nanobodies-hybrid-2nd-edition**)